A good trail result offset by a poor Trail design and implementation.
They knew the scar are +12 years old but still went ahead, and only 3 months.
If they enrolled younger scars for 3 more months the result would be fantastic.
A big thumb up for the drug but a thumb down for Gary's skill of management and Quality Control, PXS is too small to waste time and fund like this.
Much younger scars for 6 months will definitely see the trail with huge success. the share price should be 10 times more than it is now.
- Forums
- ASX - By Stock
- Ann: PXS Announces Encouraging Results from Phase 1c Scar Study
A good trail result offset by a poor Trail design and...
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.002(5.26%) |
Mkt cap ! $47.76M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 3.7¢ | $28.27K | 721.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49609 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 288388 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49609 | 0.039 |
1 | 220377 | 0.037 |
2 | 213863 | 0.035 |
1 | 400000 | 0.033 |
1 | 100000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 288388 | 3 |
0.041 | 141890 | 1 |
0.045 | 45224 | 1 |
0.046 | 55076 | 1 |
0.047 | 33889 | 1 |
Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |